Zhang, C., Wang, S., Ramalingam, S., Lonial, S., Curran, W., Waller, E. K., . . . Khuri, F. R. Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: A randomized phase II study. BMJ Publishing Group.
Chicago Style (17th ed.) CitationZhang, Chao, et al. Durvalumab and Tremelimumab with or Without Stereotactic Body Radiation Therapy in Relapsed Small Cell Lung Cancer: A Randomized Phase II Study. BMJ Publishing Group.
MLA (9th ed.) CitationZhang, Chao, et al. Durvalumab and Tremelimumab with or Without Stereotactic Body Radiation Therapy in Relapsed Small Cell Lung Cancer: A Randomized Phase II Study. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.